Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells

European Journal of Endocrinology

Volumn 149, Issue 1, 2003, Pages 31-37

  Weiss, J M ^a   Krautmacher, B ^a   Polack, S ^a   Diedrich, K ^a   Ortmann, O ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; FOLLITROPIN; GANIRELIX; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; PREGNANCY ASSOCIATED PLASMA PROTEIN A; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; TRIPTORELIN;

ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; LUTEAL CELL; OVARY; OVARY FUNCTION; OVARY HYPERSTIMULATION; PREGNANCY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; UNIVERSITY HOSPITAL;

EID: 0038825593     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1490031     Document Type: Article

References (54)

1. Huirne JA & Lambalk CB. Gonadotropin-releasing-hormone receptor antagonists. Lancet 2001 358 1793-1803.
2. Clayton RN, Harwood JP & Catt KJ. Gonadotropin-releasing hormone analogue binds to luteal cells and inhibits progesterone production. Nature 1979 282 90-92.
3. Hsueh AJ & Jones PB. Extrapituitary actions of gonadotropin-releasing hormone. Endocrine Reviews 1981 2 437-461.
4. Bauer-Dantoin AC & Jameson JL. Gonadotropin-releasing hormone receptor messenger ribonucleic acid expression in the ovary during the rat estrous cycle. Endocrinology 1995 136 4432-4438.
5. Bramley TA, McPhie CA & Menzies GS. Human placental gonadotrophin-releasing hormone (GnRH) binding sites: I Characterization, properties and ligand specificity. Placenta 1992 13 555-581.
6. Chegini N, Rong H, Dou Q, Kipersztok S & Williams RS. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro. Journal of Clinical Endocrinology and Metabolism 1996 81 3215-3221.
7. Stojilkovic SS & Catt KJ. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors. Recent Progress in Hormone Research 1995 50 161-205.
8. Kakar SS, Musgrove LC, Devor DC, Sellers JC & Neill JD. Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochemical and Biophysical Research Communications 1992 189 289-295.
9. Minaretzis D, Jakubowski M, Mortola JF & Pavlou SN. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells. Journal of Clinical Endocrinology and Metabolism 1995 80 430-434.
10. Peng C, Fan NC, Ligier M, Vaananen J & Leung PC. Expression and regulation of gonadotropin-releasing hormone (GnRH) and GnRH receptor messenger ribonucleic acids in human granulosa-luteal cells. Endocrinology 1994 135 1740-1746.
11. Brus L, Lambalk CB, de Koning J, Helder MN, Janssens RM & Schoemaker J. Specific gonadotrophin-releasing hormone analogue binding predominantly in human luteinized follicular aspirates and not in human pre-ovulatory follicles. Human Reproduction 1997 12 769-773.
12. Minaretzis D, Alper MM, Oskowitz SP, Lobel SM, Mortola JF & Pavlou SN. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells. American Journal of Obstetrics and Gynecology 1995 172 1518-1525.
13. Weiss JM, Oltmanns K, Gürke EM, Polack S, Eick F, Felberbaum R et al. Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. European Journal of Endocrinology 2001 144 677-685.
14. Demirel LC, Weiss JM, Polack S, Unlu C, Diedrich K & Ortmann O. Effect of the gonadotropin-releasing hormone antagonist ganirelix on cyclic adenosine monophosphate accumulation of human granulosa-lutein cells. Fertility and Sterility 2000 74 1001-1007.
15. Albano C, Smitz J, Camus M, Riethmuller-Winzen H, Van Steirteghem A & Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertility and Sterility 1997 67 917-922.
16. Diedrich K, Diedrich C, Santos E, Zoll C, Al Hasani S, Reissmann T et al. Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation. Human Reproduction 1994 9 788-791.
17. Felberbaum R, Reissmann T, Küpker W, Al Hasani S, Bauer O, Schill T et al. Hormone profiles under ovarian stimulation with human menopausal gonadotropin (hMG) and concomitant administration of the gonadotropin releasing hormone (GnRH)-antagonist Cetrorelix at different dosages. Journal of Assisted Reproduction and Genetics 1996 13 216-222.
18. Felberbaum RE, Reissmann T, Küpker W, Bauer O, Al Hasani S, Diedrich C et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. European Journal of Obstetrics, Gynecology and Reproductive Biology 1995 61 151-155.
19. Hughes EG, Fedorkow DM, Daya S, Sagle MA, Van de KP & Collins JA. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertility and Sterility 1992 58 888-896.
20. Weiss JM, Felberbaum RE, Montzka P, Ludwig M, Strik D, Bals-Pratsch M et al. Controlled ovarian hyperstimulation (COH) with recombinant FSH and concomitant midcyclic GnRH antagonist treatment (Ganirelix) at different dosages. Geburtshilfe und Frauenheilkunde 1999 59 209-214.
21. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L et al. Prospective, randomized, controlled study of in vitro fertilization - embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertility and Sterility 2000 73 314-320.
22. Albano C, Felberbaum RE, Smitz J, Riethmuller-Winzen H, Engel J, Diedrich K et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Human Reproduction 2000 15 526-531.
23. Borm G & Mannaerts B. Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Human Reproduction 2000 15 1490-1498.
24. Ludwig M, Katalinic A & Diedrich K. Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis. Archives of Gynecology and Obstetrics 2001 265 175-182.
25. Hernandez ER. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. Human Reproduction 2000 15 1211-1216.
26. el Roeiy A, Chen X, Roberts VJ, LeRoith D, Roberts CT Jr & Yen SS. Expression of insulin-like growth factor-I (IGF-I) and IGF-II and the IGF-I, IGF-II, and insulin receptor genes and localization of the gene products in the human ovary. Journal of Clinical Endocrinology and Metabolism 1993 77 1411-1418.
27. Hernandez ER, Hurwitz A, Vera A, Pellicer A, Adashi EY, LeRoith D et al. Expression of the genes encoding the insulin-like growth factors and their receptors in the human ovary. Journal of Clinical Endocrinology and Metabolism 1992 74 419-425.
28. Giudice LC. Insulin-like growth factor family in Graafian follicle development and function. Journal of the Society for Gynecologic Investigation 2001 8 S26-S29.
29. Peng X, Maruo T, Samoto T & Mochizuki M. Comparison of immunocytologic localization of insulin-like growth factor binding protein-4 in normal and polycystic ovary syndrome human ovaries. Endocrine Journal 1996 43 269-278.
30. Conover CA, Faessen GF, Ilg KE, Chandrasekher YA, Christiansen M, Overgaard MT et al. Pregnancy-associated plasma protein-A is the insulin-like growth factor binding protein-4 protease secreted by human ovarian granulosa cells and is a marker of dominant follicle selection and the corpus luteum. Endocrinology 2001 142 2155-2158.
31. Ludwig M, Albano C, Olivennes F, Felberbaum RE, Smitz J, Ortmann O et al. Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide) in controlled ovarian stimulation for IVF. Archives of Gynecology and Obstetrics 2002 266 12-17.
32. Conover CA, Oxvig C, Overgaard MT, Christiansen M & Giudice LC. Evidence that the insulin-like growth factor binding protein-4 protease in human ovarian follicular fluid is pregnancy associated plasma protein-A. Journal of Clinical Endocrinology and Metabolism 1999 84 4742-4745.
33. Ramasharma K & Li CH. Human pituitary and placental hormones control human insulin-like growth factor II secretion in human granulosa cells. PNAS 1987 84 2643-2647.
34. Clayton RN & Huhtaniemi IT. Absence of gonadotropin-releasing hormone receptors in human gonadal tissue. Nature 1982 299 56-59.
35. Latouche J, Crumeyrolle-Arias M, Jordan D, Kopp N, Augendre-Ferrante B, Cedard L et al. GnRH receptors in human granulosa cells: anatomical localization and characterization by autoradiographic study. Endocrinology 1989 125 1739-1741.
36. Fraser HM, Sellar RE, Illingworth PJ & Eidne KA. GnRH receptor mRNA expression by in-situ hybridization in the primate pituitary and ovary. Molecular Human Reproduction 1996 2 117-121.
37. Ortmann O, Weiss JM & Diedrich K. Embryo implantation and GnRH antagonists: ovarian actions of GnRH antagonists. Human Reproduction 2001 16 608-611.
38. Lin LS, Roberts VJ & Yen SS. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion. Journal of Clinical Endocrinology and Metabolism 1995 80 580-585.
39. Lin Y, Kahn JA & Hillensjo T. Is there a difference in the function of granulosa-luteal cells in patients undergoing in-vitro fertilization either with gonadotrophin-releasing hormone agonist or gonadotrophin-releasing hormone antagonist? Human Reproduction 1999 14 885-888.
40. Emons G, Ortmann O, Schulz KD & Schally A. Growth-inhibitory actions of analogues of luteinizing hormone releasing hormone on tumor cells. Trends in Endocrinology and Metabolism 1997 8 355-362.
41. Emons G, Muller V, Ortmann O & Schulz KD. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. Journal of Steroid Biochemistry and Molecular Biology 1998 65 199-206.
42. Gordon K. Gonadotropin-releasing hormone antagonists implications for oocyte quality and uterine receptivity. Annals of the New York Academy of Sciences 2001 943 49-54.
43. Adashi EY, Resnick CE, Hurwitz A, Ricciarellie E, Hernandez ER, Roberts CT et al. The intra-ovarian IGF system. Growth Regulation 1992 2 10-15.
44. Giudice LC. Insulin-like growth factors and ovarian follicular development. Endocrine Reviews 1992 13 641-669.
45. Mason HD, Willis DS, Holly JM & Franks S. Insulin preincubation enhances insulin-like growth factor-II (IGF-II) action on steroidogenesis in human granulosa cells. Journal of Clinical Endocrinology and Metabolism 1994 78 1265-1267.
46. el Roeiy A, Chen X, Roberts VJ, Shimasakai S, Ling N, LeRoith D et al. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins-1-6 and the localization of their gene products in normal and polycystic ovary syndrome ovaries. Journal of Clinical Endocrinology and Metabolism 1994 78 1488-1496.
47. Cataldo NA, Woodruff TK & Giudice LC. Regulation of insulin-like growth factor binding protein production by human luteinizing granulosa cells cultured in defined medium. Journal of Clinical Endocrinology and Metabolism 1993 76 207-215.
48. Giudice LC, Van Dessel HJ, Cataldo NA, Chandrasekher YA, Yap OW & Fauser BC. Circulating and ovarian IGF binding proteins: potential roles in normo-ovulatory cycles and in polycystic ovarian syndrome. Progress in Growth Factor Research 1995 6 397-408.
49. San Roman GA & Magoffin DA. Insulin-like growth factor-binding proteins in healthy and atretic follicles during natural menstrual cycles. Journal of Clinical Endocrinology and Metabolism 1993 76 625-632.
50. Cwyfan HS, Mason RD, Franks S & Holly JM. Modulation of the insulin-like growth factor-binding proteins by follicle size in the human ovary. Journal of Endocrinology 1997 154 35-43.
51. Chandrasekher YA, Van Dessel HJ, Fauser BC & Giudice LC. Estrogen- but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. Journal of Clinical Endocrinology and Metabolism 1995 80 2734-2739.
52. Iwashita M, Kudo Y, Yoshimura Y, Adachi T, Katayama E & Takeda Y. Physiological role of insulin-like-growth-factor-binding protein-4 in human folliculogenesis. Hormone Research 1996 46 (Suppl 1) 31-36.
53. Hourvitz A, Widger AE, Filho FL, Chang RJ, Adashi EY & Erickson GF. Pregnancy-associated plasma protein-A gene expression in human ovaries is restricted to healthy follicles and corpora lutea. Journal of Clinical Endocrinology and Metabolism 2000 85 4916-4920.
54. Chegini N, Lei ZM, Rao CV & Bischof P. The presence of pregnancy-associated plasma protein-A in human corpora lutea: cellular and subcellular distribution and dependence on reproductive state. Biology of Reproduction 1991 44 201-206.